SS Innovations International, Inc. (NASDAQ: SSII), a developer of surgical robotic technologies, reported that its SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console were used in successful telesurgeries during two international medical conferences in October 2026. The demonstrations underscore the company’s efforts to make robotic surgery more accessible and affordable across geographies.
At the European Association for Cardio-Thoracic Surgery Annual Meeting in Barcelona, Spain, Chairman and CEO Dr. Sudhir Srivastava performed a robotic-assisted cardiac procedure remotely on a patient located in Bengaluru, India, approximately 7,500 miles away. The procedure highlighted the potential of telesurgery to bridge distance barriers for complex cardiac care. Separately, at the Society of Robotic Surgery India Conference in New Delhi, four surgeons completed four robotic-assisted telesurgeries covering kidney, colorectal, pediatric urological and gynecological procedures. These cases demonstrated the system’s versatility across multiple surgical specialties.
The SSi MantrAsana console is designed to enable real-time remote surgery through ultra-low latency connectivity, high-definition visualization and precise instrument control. As of October 23, 2026, a total of 205 telesurgeries, including complex cardiac procedures, had been performed using the SSi Mantra system. This cumulative experience suggests that remote robotic surgery is moving from concept toward clinical routine, with implications for patients in underserved or remote regions who may gain access to specialized surgical expertise without traveling long distances.
SS Innovations, headquartered in India and a U.S. company, focuses on expanding the global presence of its surgical robotic solutions. Its product range includes the SSi Mantra system and the SSi Mudra suite of surgical instruments, which support a variety of procedures including cardiac surgery. The company’s modular multi-arm system features three to five robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, and the ability to superimpose 3D models of diagnostic imaging. The optional SSi MantrAsana console is a portable alternative to the standard command center, intended to provide equivalent control functionality while enabling enhanced portability and telesurgery capability. The SSi Mantra utilizes over 40 different types of robotic endo-surgical instruments, including 5mm instruments for pediatric and ENT surgeries, and has been clinically validated in India in more than 190 different types of surgical procedures.
For investors and industry observers, the announcements provide tangible evidence of the company’s telesurgery capabilities in high-profile international settings. The successful remote cardiac procedure across 7,500 miles may signal progress toward reducing geographic disparities in surgical care, while the multi-specialty cases in New Delhi illustrate broader applicability. As healthcare systems worldwide grapple with surgeon shortages and unequal access to advanced care, technologies that enable remote surgery could become increasingly relevant. The company’s progress is detailed in its newsroom at https://ibn.fm/SSII, and additional information is available through https://ibn.fm/Ujtlm. The full release can also be viewed at www.newmediawire.com. For more on the company, visit ssinnovations.com.
